Agonists and Antagonists Targeting the Different α2-Adrenoceptor Subtypes

Author(s): Francesco Gentili, Maria Pigini, Alessandro Piergentili, Mario Giannella.

Journal Name: Current Topics in Medicinal Chemistry

Volume 7 , Issue 2 , 2007

Become EABM
Become Reviewer

Abstract:

Chemical and biological strategies have provided evidence for α2-receptor heterogeneity, to date classified in three different subtypes, α2A, α2B, and α2C. These are widely distributed throughout the body and mediate numerous effects; therefore, the potential therapeutic indications of agonists and antagonists are numerous. Nevertheless, the lack of subtype-selectivity of the well-known compounds represents a major limit for their use. SAR studies may help to design new and more selective drugs.

Keywords: α2-adrenoceptor agonists, α2-adrenoceptor antagonists, α2-adrenoceptor subtypes, therapeutic uses of α2-ligands, imidazoline binding sites, α2-adrenoceptor subtypes-mediated effects

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 7
ISSUE: 2
Year: 2007
Page: [163 - 186]
Pages: 24
DOI: 10.2174/156802607779318235
Price: $58

Article Metrics

PDF: 14